company background image
524742 logo

Caplin Point Laboratories BSE:524742 Stock Report

Last Price

₹1.53k

Market Cap

₹116.4b

7D

-0.3%

1Y

76.4%

Updated

17 Jul, 2024

Data

Company Financials +

Caplin Point Laboratories Limited

BSE:524742 Stock Report

Market Cap: ₹116.4b

524742 Stock Overview

Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.

524742 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends5/6

Caplin Point Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Caplin Point Laboratories
Historical stock prices
Current Share Price₹1,530.75
52 Week High₹1,617.80
52 Week Low₹838.70
Beta0.42
11 Month Change10.89%
3 Month Change16.49%
1 Year Change76.37%
33 Year Change114.65%
5 Year Change296.52%
Change since IPO695,695.45%

Recent News & Updates

Recent updates

Shareholder Returns

524742IN PharmaceuticalsIN Market
7D-0.3%0.8%0.8%
1Y76.4%51.4%45.4%

Return vs Industry: 524742 exceeded the Indian Pharmaceuticals industry which returned 51.4% over the past year.

Return vs Market: 524742 exceeded the Indian Market which returned 45.4% over the past year.

Price Volatility

Is 524742's price volatile compared to industry and market?
524742 volatility
524742 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 524742 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524742's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19901,642Sridhar Ganesanwww.caplinpoint.net

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.

Caplin Point Laboratories Limited Fundamentals Summary

How do Caplin Point Laboratories's earnings and revenue compare to its market cap?
524742 fundamental statistics
Market cap₹116.35b
Earnings (TTM)₹4.57b
Revenue (TTM)₹16.94b

25.5x

P/E Ratio

6.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524742 income statement (TTM)
Revenue₹16.94b
Cost of Revenue₹7.24b
Gross Profit₹9.70b
Other Expenses₹5.13b
Earnings₹4.57b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)60.13
Gross Margin57.25%
Net Profit Margin26.98%
Debt/Equity Ratio0.01%

How did 524742 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

9%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.